Latest drug discovery Stories
SAN DIEGO, Dec. 19, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.
The Center for Healthcare Innovation at Stevens Institute of Technology has received a donation of laboratory instruments, valued at more than $251,500, to establish a new Biophysical Chemistry
NEW YORK and MILAN, Italy, Dec.
-- Statistically Significant Data from Phase 2 Study Support Safety and Efficacy of Once Daily Dosing of NK-1 Antagonist, VPD-737 (serlopitant) SOUTH SAN FRANCISCO, Calif., Dec.
MILAN, December 17, 2014 /PRNewswire/ -- - The new Dompe website aims at becoming nothing less than a hub of information concerning the biopharmaceutical
New Cardiac Safety Methodology from iCardiac Technologies Offers Earlier Cardiac Safety Characterization and Significant Cost Savings ROCHESTER, New York, December 15, 2014 /PRNewswire/ --
LONDON and BOSTON, December 15, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is pleased to announce
UPPSALA, Sweden, December 15, 2014 /PRNewswire/ -- Beactica, the Swedish fragment-based drug discovery company, today announced the closure of a financing round to progress
The global protein characterization market was valued at $1,569.00 million in 2014 and is poised to grow at a CAGR of 10.63% between 2012 and 2019, to reach $2,600.28 million in 2019.
- a meat pie that is usually eaten at Christmas in Quebec